Therapeutic potential of Triphala and Gomutra in the management of non-alcoholic fatty liver disease: A review

Abstract

Abstract Non-alcoholic fatty liver disease is a medical burden that is rapidly increasing globally. It is believed to be a complication of metabolic syndrome. It frequently coexists with one or more symptoms of the metabolic syndrome. Metabolic syndrome is closely related to the range of illnesses listed under Santarpanajanya Vyadhi (diseases due to over-nutrition) as per Ayurveda. The conventional medical system has less to offer for treating non-alcoholic fatty liver disease. Ayurveda has tremendous scope in the treatment of these types of diseases. Triphala and Gomutra (cow urine) are reputed drugs in Ayurveda. These are mentioned for treating diseases caused by Santarpana (over-nutrition). Hence, an attempt has been made to review the properties of Triphala and Gomutra (cow urine) to emphasize their utility in treating Santarpanajanya Vyadhi (diseases due to over-nutrition) with special reference to non-alcoholic fatty liver disease. The properties and pharmacological actions of Triphala and Gomutra (cow urine) can be used to manage non-alcoholic fatty liver disease.